Nigeria reveals drug they use in treating coronavirus

Ehanire

By Comrade Nnadi Goodluck

The Nigerian Government has finally revealed the drug the use in curing coronavirus patients.

This was disclosed during a press briefing on Tuesday by the Minister of Health, Osagie Ehanire.

The Minister revealed that Nigeria is currently using Remdesivir, an antiretroviral drug, in treating COVID-19 patients.

He said: “We have been using Remdesivir, we have tried that in Lagos too.

“So, we have tried the antiretroviral drug to see what effect it has.”

Osagie added that Nigeria has now moved from disease importation to community spread.

SEE ALSO:  Ebonyi State confirms first case of coronavirus

This revelation by the minister is coming barely four days after the US Food and Drug Administration (FDA) approved emergency use of Remdesivir, for treatment of the disease. The emergency FDA authorisation is not the same as formal approval, which requires a higher level of review.

The US National Institute of Health said the drug proved effective against the new coronavirus disease.

Remdesivir is originally a drug developed as a potential treatment for Ebola. It is produced by Gilead pharmaceutical company.

The drug is said to only interfere with the genome of coronavirus, disrupting its ability to replicate.

SEE ALSO:  FG lifts ban on interstate travels, okays re-opening of schools for only graduating students

According to reports in UK, the drug has a 10-day dosing duration for patients on ventilators and five days for patients who are not.

Updated: May 5, 2020 — 9:50 pm

The Author

Comrade Nnadi Goodluck

Comrade Nnadi Goodluck started writing since 2007. In 2016, he graduated from Nnamdi Azikiwe University, Awka, Anambra with a Degree in Educational Management and Policy/Health Education. He did his NYSC in Oyo state.

1 Comment

Add a Comment
  1. Keep the fire burning my brother, the hacklord. One day, nations will come to your rising.

Leave a Reply

Your email address will not be published. Required fields are marked *